​Covid19 Update: We at StageZero Life Sciences want to assure our clients and shareholders that we are monitoring the coronavirus (COVID-19) situation closely. Our lab is currently open, and we are enacting safety measures around COVID-19. We will continue to monitor the situation and respond as appropriate. 

​For patients who want access to our tests without having to visit your doctor’s office, we have telehealth physicians available, small regional labs and mobile phlebotomists who can come to your home. For more information call 1-855.420-7140 X 2066.

---

Something Small is Happening - And It's Pretty Big!                                

Small, Subtle Changes in Your Messenger RNA (mRNA) Can Identify Cancer Early - And We've Developed the Science that Finds Them

Most people think of cancer as changes, or mutations, in the sequence of DNA that lead to uncontrolled cell division. However, in between DNA and proteins (your cell's building blocks) is another layer of information called messenger RNA (mRNA) and it’s a crucial link to finding cancer. Changes in mRNA expression can be measured in blood and serve as specific early cancer indicators for cancer and other diseases. StageZero Life Sciences discovered this principle, named it the Sentinel Principle®​, and patented the technology platform behind it. The Sentinel Principle has already been used to develop the first liquid biopsy for Colorectal Cancer (ColonSentry®) and is the foundation of Aristotle® - our next generation test for multiple cancers.

Our Science

Latest News

StageZero Life Sciences to participate in Mercer’s new vendor database in the U.S.​

January 30, 2020 - StageZero Life Sciences, Ltd (TSX:SZLS) ("StageZero" or the "Company") today announced that it is participating in a Mercer internal vendor intelligence database available to Mercer Consultants to be able to do streamlined health and benefits vendor research on behalf of their clients in the U.S.

REad More

---

StageZero CEO Participates in Liquid Biopsy Webinar

Chairman and CEO, James Howard-Tripp was recently asked to be a key presenter in a Petri Dish Webinar on Liquid Biopsy sponsored by Lighthouse Laboratory Services. This presentation is now available online. .

Watch Presentation

We Empower Physicians to Find Cancer Early

Our easy-to-read reports identify your patients' cancer risks and provide guidance​ for appropriate clinical interventions. We currently offer advanced biomarker testing for Colorectal, Lung, Prosate and Breast Cancers. Enroll your practice today, and be on the cutting edge of early cancer detection.

GET STARTED

We Give Patients a Head Start Against Cancer

The worst cancer diagnosis is a late one, yet more than 40% of cancers are still found in the later stages.  We offer advanced biomarker testing for prostate, lung and breast cancer, including our mRNA test for Colorectal Cancer. Talk to your doctor about getting tested.

Learn More

I Would Like Information About Your Tests

Fill out my online form

Latest News

References

1. Siegel RL, Miller KD, Jemal A. Cancer Statistics 2017. CA Cancer J Clin. 2017; 1: 7-30